NO992579L - Antigenspesifikk IgM-deteksjon - Google Patents

Antigenspesifikk IgM-deteksjon

Info

Publication number
NO992579L
NO992579L NO992579A NO992579A NO992579L NO 992579 L NO992579 L NO 992579L NO 992579 A NO992579 A NO 992579A NO 992579 A NO992579 A NO 992579A NO 992579 L NO992579 L NO 992579L
Authority
NO
Norway
Prior art keywords
antigen
antibodies
specific
specific igm
determination
Prior art date
Application number
NO992579A
Other languages
English (en)
Other versions
NO992579D0 (no
Inventor
Elke Faatz
Urban Schmitt
Beatus Ofenloch-Hohnle
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO992579D0 publication Critical patent/NO992579D0/no
Publication of NO992579L publication Critical patent/NO992579L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Fremgangsmåte for bestemmelse av antigenspesifikke antistoffer av immunglobulinklasse M i nærvær av immunglobuliner av klasse G og/eller reumatoide faktorer i kroppsvæsker ved inkubering ved minst to ulike reseptorer Rt og R2 og eventuelt ytterligere reseptorer, der en vesentlig bestanddel av R2 er en bindingspartner i polymer form og IgG- antistoffer med.tilsvarende antigenspesifisitet dempes ved bindingspartner i monomer form; et reagens for bestemmelse av et antigenspesifikt antistoff av immunglobulinklasse M, så vel som anvendelse av bindingspartneren i monomer form for demping av IgG- antistoffer ved bestemmelse av antigenspesifikke IgM-antistoffer.
NO992579A 1996-11-29 1999-05-28 Antigenspesifikk IgM-deteksjon NO992579L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis
PCT/EP1997/006583 WO1998023955A2 (de) 1996-11-29 1997-11-26 ANTIGENSPEZIFISCHER IgM-NACHWEIS

Publications (2)

Publication Number Publication Date
NO992579D0 NO992579D0 (no) 1999-05-28
NO992579L true NO992579L (no) 1999-07-28

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992579A NO992579L (no) 1996-11-29 1999-05-28 Antigenspesifikk IgM-deteksjon

Country Status (18)

Country Link
US (1) US6489129B1 (no)
EP (1) EP0944832B1 (no)
JP (1) JP3958797B2 (no)
KR (1) KR20000057315A (no)
CN (1) CN1245560A (no)
AR (1) AR009638A1 (no)
AT (1) ATE204082T1 (no)
AU (1) AU720123B2 (no)
BR (1) BR9714365A (no)
CA (1) CA2272302A1 (no)
DE (2) DE19649389A1 (no)
ES (1) ES2162347T3 (no)
IL (1) IL130112A0 (no)
NO (1) NO992579L (no)
NZ (1) NZ335754A (no)
TW (1) TW434405B (no)
WO (1) WO1998023955A2 (no)
ZA (1) ZA9710726B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7387890B2 (en) * 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ES2372359T3 (es) * 2007-04-20 2012-01-19 F. Hoffmann-La Roche Ag Detección de infecciones primarias por patógenos.
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3126486B1 (en) 2014-04-02 2019-07-03 Chembio Diagnostic Systems, Inc. Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜（天津）生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
EP3853612A4 (en) 2018-09-18 2021-10-27 Siemens Healthcare Diagnostics, Inc. ZIKA VIRUS IMMUNOLOGICAL ASSAY METHODS AND REAGENTS
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
WO1996003423A1 (de) * 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Hapten-markierte peptide
US6613530B1 (en) 1994-07-25 2003-09-02 Roche Diagnostics Gmbh Determination of a specific immunoglobulin using multiple antigens
DE4439452A1 (de) 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Also Published As

Publication number Publication date
DE59704261D1 (de) 2001-09-13
NO992579D0 (no) 1999-05-28
WO1998023955A3 (de) 1998-07-23
AU720123B2 (en) 2000-05-25
IL130112A0 (en) 2000-06-01
AU5751398A (en) 1998-06-22
CN1245560A (zh) 2000-02-23
DE19649389A1 (de) 1998-06-04
EP0944832B1 (de) 2001-08-08
ATE204082T1 (de) 2001-08-15
KR20000057315A (ko) 2000-09-15
EP0944832A2 (de) 1999-09-29
AR009638A1 (es) 2000-04-26
ZA9710726B (en) 1999-05-28
JP2001506749A (ja) 2001-05-22
JP3958797B2 (ja) 2007-08-15
WO1998023955A2 (de) 1998-06-04
ES2162347T3 (es) 2001-12-16
CA2272302A1 (en) 1998-06-04
BR9714365A (pt) 2000-03-21
NZ335754A (en) 2001-05-25
US6489129B1 (en) 2002-12-03
TW434405B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
NO992579L (no) Antigenspesifikk IgM-deteksjon
NO992578L (no) Antigenspesifikk IgG-deteksjon
NO970292L (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
ATE314653T1 (de) Immunoassay für c-reaktives protein
DK155967C (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
Lindström et al. IgG autoantibody to human serum albumin studied by the ELISA‐technique
ATE92189T1 (de) Immunoglobulin-bestimmungsverfahren.
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
Tarkowski et al. False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents
KR930008155A (ko) 씨형 간염 바이러스(hcv)에 대한 모노클로날 항체
KR890014729A (ko) 비-a, 비-b형 간염 감염된 간에 대한 모노클로날 항체의 제조방법
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
EP0366092A3 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays
Koch et al. Semi-quantitative assessment of anti-insulin total IgG and IgG sub-classes in insulin-immunized patients using a highly sensitive immunochemical micromethod
DE59309215D1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes
DK230485A (da) Fremgangsmaade til bestemmelse af atl virusantistof og reagens dertil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application